Price T Rowe Associates Inc Abiomed Inc Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $282,985 - $351,803	-1,167 Reduced 0.88%	130,875 $32.2 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $1.01 Million - $1.52 Million	-4,492 Reduced 3.29%	132,042 $32.7 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $1.24 Million - $1.64 Million	-4,490 Reduced 3.18%	136,534 $45.2 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $132,878 - $164,136	-442 Reduced 0.31%	141,024 $50.7 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $372,228 - $451,440	-1,200 Reduced 0.84%	141,466 $46.1 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $650,469 - $869,496	2,476 Added 1.77%	142,666 $44.5 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $53,752 - $66,764	-188 Reduced 0.13%	140,190 $44.7 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $35.4 Million - $45.5 Million	140,378 New	140,378 $45.5 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.